The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1412
March 18, 2013
View Complete Issue         Table of Contents 2019 
Mitomycin Solution (Mitosol) for Glaucoma Surgery
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Mitomycin Solution (Mitosol) for Glaucoma Surgery
March 18, 2013 (Issue: 1412)
A topical formulation of the antimetabolite mitomycin (Mitosol – Mobius Therapeutics) has been approved by the FDA for adjunctive use in glaucoma surgery to reduce scarring. Compounding pharmacies have supplied the drug off-label for this...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Mitomycin Solution (Mitosol) for Glaucoma Surgery
Article code: 1412c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.